Cleo Labs, Inc — Form D/A
Cleo Labs, Inc of San Francisco, CA, a company, filed a Form D amendment with the SEC on 2020-12-03. The offering totals $32.4M, of which $31.2M was reported sold. Industry: Other Technology.
Offering
- Filed: 2020-12-03
- Form: D/A
- Accession: 0001723292-20-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $32.4M
- Amount sold: $31.2M
- Remaining: $1.2M
- Investors: 17
- Date of first sale: 2018-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-336534
Issuer
- Name: Cleo Labs, Inc
- CIK: 0001723292
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 85 2nd Street Suite 710, San Francisco, CA, 94105
- Phone: (415) 935-1009
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Michael Dixon | Director | Boston, MA |
| Sarah Guo | Director | San Francisco, CA |
| Sarah Guo | Related Person | San Francisco, CA |
| Karin Ajmani | Director | New York, NY |
| Vanessa Larco | Director | San Francisco, CA |
| Vanessa Larco | Related Person | San Francisco, CA |
| Sarahjane Sacchetti | Director | San Francisco, CA |
| Sarahjane Sacchetti | Executive Officer | San Francisco, CA |
| Amy Kux | Executive Officer | San Francisco, CA |
| Shannon Spanhake | Director | San Francisco, CA |
| Shannon Spanhake | Executive Officer | San Francisco, CA |
| Shannon Spanhake | Related Person | San Francisco, CA |
Other filings by this issuer (4)
More